Cuizon, Edraline .
HRN: 14-84-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFUROXIME 750MG (VIAL)
12/19/2023
12/21/2023
IV
1.5g
Q8 X 6 Doses
S/P Repeat LTCS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes